News
-
PD breaking news – Blackmores CEO & MD Richard Henfrey resigns
Tuesday | Feb 26 2019Blackmores CEO & MD Richard Henfrey resigns Listed complementary medicines company Blackmores had announced the resignation.
-
Pharmacy wins cosmetics race
Tuesday | Feb 26 2019MORE than 5.3 million Australian women purchase cosmetics in an average six months, up from under 4.8 million women in 2014, according to the latest Roy Morgan Research data.
-
Voter health and costs angst
Tuesday | Feb 26 2019THE Ipsos Issues Monitor survey published in Fairfax media over the weekend has confirmed the time is right for action to address voters' concerns about health and the cost of living, a Pharmacy Guild of Australia spokesperson said.
-
MedAdvisor revenue >$2m
Tuesday | Feb 26 2019LISTED digital medication management company MedAdvisor has recorded its first quarter with revenue exceeding $2 million.
-
Vaccination access is key
Tuesday | Feb 26 2019THERE are two main contributors to under-vaccination: "acceptance and access" factors, according to an Insight article in the latest MJA.
-
MHR 90% uptake
Tuesday | Feb 26 2019BASED on the number of people eligible for Medicare as at 31 Jan 2019 (25,459,544), the participation rate in My Health Record (MHR) is 90.1%, which means a national opt-out rate of 9.9%, the Australian Digital Health Agency has announced.
-
APC Colloquium open
Tuesday | Feb 26 2019REGISTRATIONS are now open to attend the Australian Pharmacy Council's (APC's) Colloquium in May this year.
-
Rash of new risks
Tuesday | Feb 26 2019THE Therapeutic Goods Administration (TGA) has warned of more dangerous goods flooding into Australia via online purchases, especially weight-loss products.
-
Diabetes vit C boost
Tuesday | Feb 26 2019VITAMIN C may prove to be a low-cost option to support people living with diabetes according to a new Deakin Uni study published in the Diabetes, Obesity and Metabolism Journal.
-
New AusCann CEO
Tuesday | Feb 26 2019LISTED medicinal cannabis company AusCann has announced the appointment of global pharmaceutical business executive, Ido Kanyon, as Chief Executive Officer commencing 22 May 2019.
